Product Categories
| Country: | China |
|---|---|
| Tel: | 0513-66337626 |
| Mobile: | 18051384581 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| (R)-HTS-3 | C17H18F2N2O | 2771208-83-2 | Details |
| NVP-CLR457 | C18H20F3N7O4 | 1453082-52-4 | Details |
| ORIC-101 | C34H47NO2 | 2222344-98-9 | Details |
| A-794282 | C19H18N4OS | 869802-44-8 | Details |
| SiR-COOH | C27H28N2O4Si | 1418275-26-9 | Details |
| PCSK9 degrader 1 | C34H34FN3O6S | 2215931-60-3 | Details |
| O6-Methyl-7,8-dihydro-6-isomorphine | C18H23NO3 | 63732-74-1 | Details |
| Ibuzatrelvir/PF-07817883 | C21H30F3N5O5 | 2755812-39-4 | Details |
| GNE684 | C23 H24 N6 O3 | 2438637-64-8 | Details |
| GNE-6893 | C23H24FN5O4 | 2415374-98-8 | Details |
| (Rac)-Lisaftoclax/(Rac)-APG-2575 | 2651980-10-6 | Details |
| RGB-286638 | C29H37Cl2N7O4 | 784210-87-3 | Details |
| Granisetron EP Impurity F | C18H24N4O | 1364914-39-5 | Details |
| DO-264 | C23H20Cl2F3N5O2S | 2301866-59-9 | Details |
| Cy5.5 alkyne | C43H46ClN3O | 1628790-37-3 | Details |
| U-63557A | C15H12NNaO3 | 85666-17-7 | Details |
| EP 157 | C29H33NO3 | 101910-65-0 | Details |
| Enerisant | C22H30N4O3 | 1152747-82-4 | Details |
| Elubrixin/SB-656933 | C17H17Cl2FN4O4S | 688763-64-6 | Details |
| DRL-17822 | C30H31F6N7 | 898911-09-6 | Details |
| FATP1-IN-1 | C18H22FN5OS | 1431945-95-7 | Details |
| 2,4,6-Pyrimidinetriamine,N4-(4-iodophenyl)-5-nitro- | C10H9IN6O2 | 6036-52-8 | Details |
| eCF506 | C26H38N8O3 | 1914078-41-3 | Details |
| E6201 | C21H27NO6 | 603987-35-5 | Details |
| ERK Inhibitor II (Negative control) | C18H12N6O | 1177970-73-8 | Details |
| 5-DIETHYLAMINO-NAPHTHALENE-1-SULFONYL CHLORIDE | C14H16ClNO2S | 76264-86-3 | Details |
| O-Demethyl Lenvatinib | C20H17ClN4O4 | 417717-04-5 | Details |
| 3-O-Methyl Estradiol | C19H26O2 | 1035-77-4 | Details |
| MSC2360844 | C26H27FN4O5S | 1305267-37-1 | Details |
| Fosfomycin | C3H7O4P | 23155-02-4 | Details |
| Eribaxaban | C24H22ClFN4O4 | 536748-46-6 | Details |
| MethADP | C11H17N5O9P2 | 3768-14-7 | Details |
| Etavopivat | C22H23N3O6S | 2245053-57-8 | Details |
| CCT 241533 | C23H27FN4O4 | 1262849-73-9 | Details |
| Atuzabrutinib | C30H30FN7O2 | 1581714-49-9 | Details |
| AG-17724 | C21H16FN3O3 | 884033-66-3 | Details |
| AZD9898 | C20H19ClF3N3O4 | 2042347-69-1 | Details |
| Asundexian/BAY-2433334 | C26H21ClF4N6O4 | 2064121-65-7 | Details |
| BAY-545 | C18H22F3N3O4S | 1699717-32-2 | Details |
| KAF156/GNF156 | C22H23F2N5O.ClH | 2751586-94-2 | Details |
| MS31 trihydrochloride | Details |
| BMVC-8C3O | C42H53IN4O3+2 | 1301708-12-2 | Details |
| Ciglitazone | C18H23NO3S | 74772-77-3 | Details |
| Lovastatin sodium salt | C24H39NaO6 | 75225-50-2 | Details |
| CDK9-IN-2 | C23H25ClFN5 | 1263369-28-3 | Details |
| FLT3 Inhibitor III | C21H23N3OS | 852045-46-6 | Details |
| FK788 | C26H25NO6 | 227951-89-5 | Details |
| Ficellomycin | C13H24N6O3 | 59458-27-4 | Details |
| Famitinib | C23H27FN4O2 | 945380-27-8 | Details |
| HAMI 3379 | C34H45NO8 | 1245653-57-9 | Details |
| KAG-308 | C24H30F2N4O3 | 1215192-68-9 | Details |
| Ebaresdax/ACP-044 | C12H14N2O3S | 1334471-39-4 | Details |
| ERK inhibitor III | C12H10N6O5 | 345616-52-6 | Details |
| Entacapone | 116314-67-1 | Details |
| E-4031 | C21H27N3O3S | 113558-89-7 | Details |
| Eteplirsen | 1173755-55-9 | Details |
| FTY720 (R)-Phosphate | C19H34NO5P | 402616-23-3 | Details |
| Florbetapir F-18 | C20H25FN2O3 | 956103-76-7 | Details |
| fosbretabulin disodium | C18H21O8P | 222030-63-9 | Details |
| ERD-308 | C55H65N5O9S2 | 2320561-35-9 | Details |
| Elacestrant | C30H38N2O2 | 722533-56-4 | Details |
| 2-fluoro MT-45 (hydrochloride) | C24H33Cl2FN2 | 2748592-60-9 | Details |
| INCB059872 | C23H34N2O3 | 1802909-49-4 | Details |
| RG7800/RO6885247 | C24H28N6O | 1449598-06-4 | Details |
| Thalidomide-Piperazine-PEG1-NH2 | C21H27N5O5 | 2357111-29-4 | Details |
| JB061 | C8H11NO | 5071-96-5 | Details |
| PF 4693627 | C26H29Cl2N3O3 | 1312815-93-2 | Details |
| NAPQI | C8H7NO2 | 50700-49-7 | Details |
| Oxythiamine diphosphate | C12H17N3O8P2S | 10497-04-8 | Details |
| PROTAC BRD9-binding moiety 1 hydrochloride | C23H25N3O7S2.ClH | 2448414-41-1 | Details |
| Oleoyl coenzyme A lithium salt | C39H69LiN7O17P3S | 188824-37-5 | Details |
| Thalidomide-Piperazine-PEG3-COOH | C26H34N4O9 | 2797619-63-5 | Details |
| Isoproterenol | C11H17NO3 | 7683-59-2 | Details |
| DS-3801b | C28H39N3O3 | 1369412-66-7 | Details |
| Fipravirimat | C43H67FN2O4S | 1818867-24-1 | Details |
| CPUY192018 | C28H26N2O10S2 | 1567836-15-0 | Details |
| Ezlopitant | C31H38N2O | 147116-64-1 | Details |
| CV-1674 | 37151-17-0 | Details |
| UT-B-IN-1 | C20H17N5O2S3 | 892742-76-6 | Details |
| CP-4126/CO-101 | C27H43F2N3O5.ClH | 2918768-08-6 | Details |
| Agistatin D | C11H14O4 | 144096-47-9 | Details |
| Thalidomide-Propargyne-PEG1-COOH | C19H16N2O7 | 2828438-36-2 | Details |
| Polyketomycin | C44H48O18 | 200625-47-4 | Details |
| ER 27319 maleate | C22H24N2O5 | 201010-95-9 | Details |
| Vulolisib | C18H19F2N5O3S | 2390105-79-8 | Details |
| TrkA-IN-3 | Details |
| PROTAC BRD4 Degrader-24 | C62H77F2N9O12S4 | 2417370-39-7 | Details |
| Flesinoxan | C22H26FN3O4 | 98206-10-1 | Details |
| MDTF free acid | C16H11F4NO9S | 2102021-49-6 | Details |
| DuP 105 | C13H16N2O4S | 96800-41-8 | Details |
| dTAGV-1 TFA | C70H91F3N6O16S | 2624313-15-9 | Details |
| Binodenoson/MRE-0470;/WRC 0470 | C17H25N7O4 | 144348-08-3 | Details |
| Fluparoxan | C10H10FNO2 | 105182-45-4 | Details |
| Mc-Val-Cit-PAB-Gefitinib | C50H63ClFN10O9+ | 2055897-01-1 | Details |
| Dup-721 | C14H16N2O4 | 104421-21-8 | Details |
| DSM502 | C16H16F3N3O | 2426616-55-7 | Details |
| RSV-IN-1 | C20H21N5O4S | 861139-16-4 | Details |
| Draflazine | C30H33Cl2F2N5O2 | 120770-34-5 | Details |
| NISTC71476 | CHO2- | 71-47-6 | Details |
| KDM2B-IN-4 | C24H28N2O2 | 1966933-85-6 | Details |
| Product Total： Product Page： | ||||
| 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 | ||||